3-acetoxy-5-methyl-benzoic acid methyl ester | 26613-68-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-acetoxy-5-methyl-benzoic acid methyl ester
• 英文别名: 3-Acetoxy-5-methyl-benzoesaeure-methylester；Methyl 3-acetyloxy-5-methylbenzoate
• CAS: 26613-68-3
• 化学式: C₁₁H₁₂O₄
• 分子量: 208.214
• InChiKey: RTDQFBNMFNFXRM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-acetoxy-5-methyl-benzoic acid methyl ester 在 四氯化碳 、 溴 作用下， 生成 3-acetoxy-5-bromomethyl-benzoic acid methyl ester
  参考文献：
  名称：

  Synthesis of Reserpine Analogs^1,2

  摘要：

  DOI：

  10.1021/jo01094a031
• 作为产物：
  描述：

  3-羟基-5-碘苯甲酸甲酯 、 乙酸酐 生成 3-acetoxy-5-methyl-benzoic acid methyl ester
  参考文献：
  名称：

  Bergmann, Chemische Berichte, 1932, vol. 65, p. 1489,1492

  摘要：

  DOI：

文献信息

• 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS
  申请人：OM Pharma SA

  公开号：EP3878837A1

  公开（公告）日：2021-09-15

  The invention provides hydroquinone derivatives of formula (I), processes of preparation, as well as pharmaceutical compositions and methods of treating and/or preventing e.g. autoimmune, immunological, rheumatology, vascular, ophthalmologic, fibrotic, metabolic and gastro-intestinal disorders, neuroinflammatory and neurodegenerative diseases, neoplasms and cancer associated disorders, hormone related diseases and immunological disorders resulting from viral and bacterial infectious diseases and complications thereof. wherein: Ra, Rb = H, acyl or aryl alkyl; R1 = COOR4, (CH2)nCOOR4, SO3H, (CH2)nSO3H or CONH-R10; R2 and R3 = H or R5, with the proviso that when one of R2 and R3 is R5, the other is H; R4 = H, alkyl or aryl alkyl; R5 = R6, R7 or R8; R6 = CONH-R9, CONHCOR9, CONH(CH2)n- R9, CONHCH(COOR4)(CH2)k R9 or heteroaryl-R9; k = 0-4; R7 = optionally substituted benzoheteroaryl ; R8 = (CH 2)mX(CH2)p R9; X = O, S, SO2, NH, NAc or N(CH2)q R9; R9 = optionally substituted aryl, heteroaryl or cycloalkyl ; R10 = optionally substituted aryl or heteroaryl ; n, m, p and q = independently 1-4.

  该发明提供了公式（I）的氢醌衍生物，制备方法，以及治疗和/或预防例如自身免疫、免疫学、风湿学、血管学、眼科学、纤维化、代谢和胃肠道疾病、神经炎症和神经退行性疾病、肿瘤和癌症相关疾病、激素相关疾病以及由病毒和细菌感染疾病及其并发症引起的免疫疾病的药物组合物和治疗方法。其中：Ra、Rb = H、酰基或芳基烷基；R1 = COOR4、（CH2）nCOOR4、SO3H、（CH2）nSO3H或CONH-R10；R2和R3 = H或R5，但当R2和R3中的一个为R5时，另一个为H；R4 = H、烷基或芳基烷基；R5 = R6、R7或R8；R6 = CONH-R9、CONHCOR9、CONH（CH2）n-R9、CONHCH（COOR4）（CH2）kR9或杂环芳基-R9；k = 0-4；R7 = 可选取代的苯杂环芳基；R8 =（CH2）mX（CH2）pR9；X = O、S、SO2、NH、NAc或N（CH2）qR9；R9 = 可选取代的芳基、杂环芳基或环烷基；R10 = 可选取代的芳基或杂环芳基；n、m、p和q = 独立地为1-4。
• Binuclear metal complexes for use as emitters in organic electroluminescent devices
  申请人：Merck Patent GmbH

  公开号：US11136343B2

  公开（公告）日：2021-10-05

  The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.

  本发明涉及双核金属络合物和电子装置，特别是含有上述金属络合物的有机电致发光装置。
• HERBIZID WIRKSAME 3-PHENYLISOXAZOLINDERIVATE
  申请人：Bayer CropScience AG

  公开号：EP2900645A1

  公开（公告）日：2015-08-05
• BINUKLEARE METALLKOMPLEXE FÜR DEN EINSATZ ALS EMITTER IN ORGANISCHEN ELEKTROLUMINESZENZVORRICHTUNGEN
  申请人：Merck Patent GmbH

  公开号：EP3515925B1

  公开（公告）日：2020-10-21
• BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES
  申请人：Merck Patent GmbH

  公开号：US20190292210A1

  公开（公告）日：2019-09-26

  The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.